Facial Contouring

Myth Check · August 1, 2026 · 5 min · By Farid Castellano

Masseter Botox for Jaw Slimming: What the Muscle Actually Does, and What Injections Can and Cannot Change

Neurotoxin injections into the masseter are one of the most requested lower-face contouring treatments. Here is a plain-English look at the mechanism, who tends to respond, and the myths that deserve a closer look.

Masseter Botox for Jaw Slimming: What the Muscle Actually Does, and What Injections Can and Cannot Change

Ask injectors what patients request most often for the lower face, and masseter reduction comes up quickly. The pitch sounds simple: inject botulinum toxin into the chewing muscle at the angle of the jaw, the muscle shrinks, and a square face becomes a slimmer, more tapered one. The mechanism is real, but the marketing around it often skips the details that determine whether a given person will actually see a change. This piece walks through the physiology and checks the most common claims against it.

The mechanism, in plain terms. The masseter is one of the strongest muscles in the body relative to its size. It runs from the cheekbone down to the angle of the mandible and does most of the work of clenching and chewing. Botulinum toxin blocks the release of acetylcholine at the neuromuscular junction, which means the nerve can no longer tell treated muscle fibers to contract. A muscle that contracts less begins to atrophy, the same way an arm shrinks inside a cast. That atrophy, not the injection itself, is what slims the jawline. This is why results build slowly. Weakening starts within one to two weeks, but visible volume loss typically takes six to twelve weeks as disuse atrophy accumulates.

Myth one: it works for every wide jaw. This is the biggest source of disappointment. Lower-face width comes from three possible sources: masseter muscle bulk, the bone of the mandible itself, and overlying fat. Toxin only addresses the first. A quick clinical test separates them: clench the teeth hard while palpating the jaw angle. If a firm mass visibly bulges and softens on release, muscle is a major contributor and toxin is likely to help. If the width feels bony and unchanging, no amount of neurotoxin will narrow it, because the mandibular angle is skeletal. If the fullness is soft and pinchable, fat is the driver and a different conversation is needed. People with masseter hypertrophy from chronic clenching or bruxism tend to be the strongest responders.

Myth two: results are permanent, or the opposite claim, that they vanish in three months. Neither is quite right. The toxin effect on nerve signaling wears off over roughly three to four months as new nerve terminals sprout. But the atrophy takes longer to reverse than the paralysis does, because the muscle has to rebuild lost bulk through use. In practice, contour changes often last four to six months or longer after a single treatment, and repeated cycles can produce more durable thinning. If treatment stops entirely and the person keeps clenching, the muscle generally rebuilds over months to a year or more. It is maintenance, not a one-time fix, but the maintenance interval is often longer than for forehead lines.

Myth three: it is purely cosmetic. Masseter injection has a parallel functional use. The same dosing that slims the muscle reduces clenching force, which is why it is studied and used for bruxism and some temporomandibular symptoms. Many patients seeking jaw slimming also grind their teeth at night, and the two goals overlap. That said, someone with jaw joint pain should be evaluated properly rather than assuming toxin is the answer, since joint pathology and muscle overactivity are different problems that sometimes coexist.

Myth four: there is no downside because it is just a muscle. The masseter sits in crowded anatomical territory. Inject too far forward and toxin can diffuse into the risorius or zygomaticus muscles, producing an asymmetric or stiff smile that lasts until the toxin wears off. Inject too superficially and the parotid gland or superficial fibers can be affected. There is also a structural consideration in older patients or those with thinner faces: the masseter provides some lateral support to the cheek and jowl area, and aggressive volume loss can occasionally make sagging or jowling look more prominent. Experienced injectors stay within a defined safe zone, roughly the lower posterior portion of the muscle, and dose conservatively at first, commonly in the range of 20 to 40 units per side depending on muscle bulk, with reassessment before adding more.

What a realistic outcome looks like. Studies using ultrasound and CT measurement generally show masseter thickness reductions in the range of roughly 20 to 30 percent after treatment, which translates to a visible but natural narrowing at the jaw angle in good candidates. It is a softening of the square, not a surgical jaw reshaping. Chewing feels slightly weaker for a few weeks, especially with tough foods, and this fades as other chewing muscles compensate.

The bottom line. Masseter toxin is a legitimate, mechanism-backed contouring tool for one specific problem: jaw width driven by muscle bulk. The clench test is the honest screen. If the width is bone or fat, the money is better spent elsewhere, and any injector who skips that assessment before quoting a price is selling a procedure rather than solving a problem.

More in Myth Check

View all →